Neuronetics PE Ratio 2017-2025 | STIM
Current and historical p/e ratio for Neuronetics (STIM) from 2017 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Neuronetics PE ratio as of November 17, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Neuronetics PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-11-17 | 1.65 | 0.00 | |
| 2025-09-30 | 2.73 | $-0.82 | 0.00 |
| 2025-06-30 | 3.49 | $-1.13 | 0.00 |
| 2025-03-31 | 3.68 | $-1.31 | 0.00 |
| 2024-12-31 | 1.61 | $-1.37 | 0.00 |
| 2024-09-30 | 0.76 | $-1.23 | 0.00 |
| 2024-06-30 | 1.80 | $-1.12 | 0.00 |
| 2024-03-31 | 4.76 | $-0.96 | 0.00 |
| 2023-12-31 | 2.90 | $-1.07 | 0.00 |
| 2023-09-30 | 1.35 | $-1.18 | 0.00 |
| 2023-06-30 | 2.15 | $-1.13 | 0.00 |
| 2023-03-31 | 2.91 | $-1.35 | 0.00 |
| 2022-12-31 | 6.87 | $-1.38 | 0.00 |
| 2022-09-30 | 3.18 | $-1.37 | 0.00 |
| 2022-06-30 | 3.21 | $-1.40 | 0.00 |
| 2022-03-31 | 3.03 | $-1.30 | 0.00 |
| 2021-12-31 | 4.46 | $-1.20 | 0.00 |
| 2021-09-30 | 6.56 | $-1.10 | 0.00 |
| 2021-06-30 | 16.02 | $-0.97 | 0.00 |
| 2021-03-31 | 12.37 | $-1.09 | 0.00 |
| 2020-12-31 | 11.11 | $-1.46 | 0.00 |
| 2020-09-30 | 4.86 | $-1.68 | 0.00 |
| 2020-06-30 | 1.93 | $-1.87 | 0.00 |
| 2020-03-31 | 1.89 | $-1.85 | 0.00 |
| 2019-12-31 | 4.49 | $-1.59 | 0.00 |
| 2019-09-30 | 8.31 | $-1.53 | 0.00 |
| 2019-06-30 | 12.51 | $-1.45 | 0.00 |
| 2019-03-31 | 15.25 | $-31.66 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.113B | $0.075B |
| Neuronetics, Inc. is a commercial-stage medical device company. It focused on designing, developing, and marketing products for patients who suffer from psychiatric disorders. NeuroStar Advanced Therapy System(R), is the transcranial magnetic stimulation treatment for depressive disorder. Neuronetics, Inc. is based in Malvern, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $213.087B | 25.32 |
| Intuitive Surgical (ISRG) | United States | $195.983B | 76.68 |
| IDEXX Laboratories (IDXX) | United States | $53.421B | 53.05 |
| Edwards Lifesciences (EW) | United States | $49.175B | 32.97 |
| Alcon (ALC) | Switzerland | $37.787B | 25.54 |
| IQVIA Holdings (IQV) | United States | $36.805B | 20.52 |
| Mettler-Toledo (MTD) | United States | $28.374B | 33.20 |
| STERIS (STE) | Ireland | $25.225B | 26.04 |
| DexCom (DXCM) | United States | $22.812B | 31.45 |
| Waters (WAT) | United States | $22.503B | 29.76 |
| Hologic (HOLX) | United States | $16.490B | 17.36 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.802B | 0.00 |
| Globus Medical (GMED) | United States | $11.194B | 23.49 |
| Penumbra (PEN) | United States | $10.907B | 76.72 |
| Masimo (MASI) | United States | $7.898B | 25.31 |
| Sysmex ADR (SSMXY) | Japan | $6.137B | 19.50 |
| Glaukos (GKOS) | United States | $5.077B | 0.00 |
| Teleflex (TFX) | United States | $4.590B | 7.31 |
| TransMedics (TMDX) | United States | $3.875B | 45.91 |
| Veracyte (VCYT) | United States | $3.105B | 35.39 |
| Alphatec Holdings (ATEC) | United States | $2.952B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.929B | 15.82 |
| Integer Holdings (ITGR) | United States | $2.351B | 11.04 |
| Artivion (AORT) | United States | $2.138B | 98.09 |
| Nihon Kohden (NHNKY) | Japan | $1.794B | 15.66 |
| Elekta AB (EKTAY) | Sweden | $1.692B | 16.39 |
| PROCEPT BioRobotics (PRCT) | United States | $1.625B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.243B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.196B | 0.00 |
| AxoGen (AXGN) | United States | $1.087B | 0.00 |
| IRadimed (IRMD) | United States | $1.087B | 51.77 |
| OPKO Health (OPK) | United States | $0.975B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.932B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.914B | 4.95 |
| SiBone (SIBN) | United States | $0.778B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.570B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.524B | 30.44 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.516B | 10.30 |
| AngioDynamics (ANGO) | United States | $0.491B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.474B | 0.00 |
| NeuroPace (NPCE) | United States | $0.431B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.409B | 0.00 |
| RxSight (RXST) | United States | $0.405B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.404B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.396B | 10.92 |
| Sight Sciences (SGHT) | United States | $0.372B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.323B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.304B | 50.65 |
| Semler Scientific (SMLR) | United States | $0.304B | 2.29 |
| Spectral Diagnostics (EDTXF) | Canada | $0.295B | 0.00 |
| CVRx (CVRX) | United States | $0.243B | 0.00 |
| 908 Devices (MASS) | United States | $0.195B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.184B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.183B | 0.00 |
| Inogen (INGN) | United States | $0.182B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.147B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.147B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.136B | 0.00 |
| LENSAR (LNSR) | United States | $0.118B | 0.00 |
| Accuray (ARAY) | United States | $0.113B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.101B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.091B | 0.00 |
| Hyperfine (HYPR) | United States | $0.088B | 0.00 |
| InspireMD (NSPR) | United States | $0.085B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.078B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.074B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.066B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.046B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.015B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Solana (HSDT) | United States | $0.005B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.07 |